Healthcare provider profile · identity verified

Heberto Z Hernandez, MD

Internal Medicine · HIGHLAND PARK, IL · NPI 1366419194

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	535	106
Amlodipine Besylate	Amlodipine Besylate	437	76
Eliquis	Apixaban	300	27
Levothyroxine Sodium	Levothyroxine Sodium	262	49
Lisinopril	Lisinopril	253	50
Metoprolol Succinate	Metoprolol Succinate	239	53
Losartan Potassium	Losartan Potassium	216	33
Gabapentin	Gabapentin	209	36
Metformin Hcl	Metformin Hcl	205	49
Pantoprazole Sodium	Pantoprazole Sodium	197	39
Sertraline Hcl	Sertraline Hcl	194	31
Furosemide	Furosemide	182	43
Quetiapine Fumarate	Quetiapine Fumarate	166	20
Omeprazole	Omeprazole	162	33
Escitalopram Oxalate	Escitalopram Oxalate	154	24
Metoprolol Tartrate	Metoprolol Tartrate	142	34
Tamsulosin Hcl	Tamsulosin Hcl	137	25
Potassium Chloride	Potassium Chloride	130	25
Memantine Hcl	Memantine Hcl	123	15
Allopurinol	Allopurinol	116	28
Donepezil Hcl	Donepezil Hcl	110	16
Carvedilol	Carvedilol	103	22
Hydroxyzine Hcl	Hydroxyzine Hcl	95	13
Mirtazapine	Mirtazapine	87	20
Xarelto	Rivaroxaban	87	suppressed
Trazodone Hcl	Trazodone Hcl	86	16
Simvastatin	Simvastatin	84	19
Jardiance	Empagliflozin	83	11
Clopidogrel	Clopidogrel Bisulfate	82	15
Hydrochlorothiazide	Hydrochlorothiazide	80	24
Levetiracetam	Levetiracetam	80	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	71	suppressed
Alprazolam	Alprazolam	63	17
Hydralazine Hcl	Hydralazine Hcl	62	14
Methylprednisolone	Methylprednisolone	61	48
Glimepiride	Glimepiride	57	15
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	54	20
Prednisone	Prednisone	53	21
Spironolactone	Spironolactone	53	13
Olanzapine	Olanzapine	52	suppressed
Bumetanide	Bumetanide	51	suppressed
Entresto	Sacubitril/Valsartan	51	suppressed
Famotidine	Famotidine	51	suppressed
Torsemide	Torsemide	51	suppressed
Celecoxib	Celecoxib	49	21
Duloxetine Hcl	Duloxetine Hcl	47	suppressed
Januvia	Sitagliptin Phosphate	47	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	45	45
Glipizide	Glipizide	45	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	43	suppressed
Metformin Hcl Er	Metformin Hcl	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Midodrine Hcl	Midodrine Hcl	42	suppressed
Amiodarone Hcl	Amiodarone Hcl	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	23
Rexulti	Brexpiprazole	39	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	29
Divalproex Sodium	Divalproex Sodium	38	suppressed
Meloxicam	Meloxicam	38	suppressed
Primidone	Primidone	38	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	38	13
Albuterol Sulfate Hfa	Albuterol Sulfate	37	17
Benazepril Hcl	Benazepril Hcl	37	suppressed
Finasteride	Finasteride	37	suppressed
Azithromycin	Azithromycin	36	21
Nyamyc	Nystatin	36	suppressed
Valsartan	Valsartan	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Latanoprost	Latanoprost	35	suppressed
Baclofen	Baclofen	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	21
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	25
Colchicine	Colchicine	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Austedo	Deutetrabenazine	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	17
Lokelma	Sodium Zirconium Cyclosilicate	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Calcium Acetate	Calcium Acetate	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Divalproex Sodium Er	Divalproex Sodium	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Clarithromycin	Clarithromycin	23	20
Clonidine Hcl	Clonidine Hcl	23	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Dantrolene Sodium	Dantrolene Sodium	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Fluconazole	Fluconazole	19	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Digoxin	Digoxin	18	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	18	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	18	suppressed
Retacrit	Epoetin Alfa-Epbx	18	suppressed
Benztropine Mesylate	Benztropine Mesylate	17	suppressed
Topiramate	Topiramate	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	11
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	12
Ozempic	Semaglutide	16	suppressed
Phenytek	Phenytoin Sodium Extended	16	suppressed
Repaglinide	Repaglinide	16	suppressed
Vancomycin Hcl	Vancomycin Hcl	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Meropenem	Meropenem	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Atenolol	Atenolol	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Risperidone	Risperidone	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Darifenacin Er	Darifenacin Hydrobromide	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Novolin R	Insulin Regular, Human	11	suppressed
Ramipril	Ramipril	11	suppressed
Steglatro	Ertugliflozin Pidolate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error